Join host Blake Adams for a conversation with Amir Lahav, Head of Digital R&D, Mitsubishi Tanabe Pharma Holdings America, about the innovative ways companies can approach decentralized trials in a post-pandemic world.

Join host Blake Adams for a conversation with Amir Lahav, Head of Digital R&amp;D, Mitsubishi Tanabe Pharma Holdings America, about the innovative ways companies can approach decentralized trials in a post-pandemic world.

Decentralized Trials in a Post-Pandemic World

The clinical research industry is changing at a rapid pace, and with good reason. Considering the gaps and issues exposed by the COVID-19 crisis, successful sites, sponsors and CROs recognize that it’s time for The Next Phase with a move toward a new, nimbler era of clinical research. Hosted by the remote site monitoring experts from Florence Healthcare, this podcast explores the new tools and practices that will better allow us to advance human health today and beyond.

Share Decentralized Trials in a Post-Pandemic World

Sign up to save your podcasts

Decentralized Trials in a Post-Pandemic World

Decentralized Trials in a Post-Pandemic World

More shows like The Next Phase: Exploring Innovation in Clinical Trials

Random Musings From The Clinical Trials Guru